The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: ITGA2B vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000419.5:c.2489T>G

CA8602667

1879014 (ClinVar)

Gene: ITGA2B (HGNC:3674)
Condition: Glanzmann thrombasthenia (MONDO:0100326)
Inheritance Mode: Autosomal recessive inheritance
UUID: 8383e80f-14d2-4c1e-8dd9-7bc707c6f685
Approved on: 2025-04-15
Published on: 2025-05-13

HGVS expressions

NM_000419.5:c.2489T>G
NC_000017.11:g.44375945A>C
CM000679.2:g.44375945A>C
NC_000017.10:g.42453313A>C
CM000679.1:g.42453313A>C
NC_000017.9:g.39808839A>C
NG_008331.1:g.18561T>G
ENST00000262407.6:c.2489T>G
ENST00000648408.1:c.1920T>G
ENST00000262407.5:c.2489T>G
ENST00000587295.5:c.141T>G
ENST00000592462.5:n.1284T>G
NM_000419.3:c.2489T>G
NM_000419.4:c.2489T>G
More

Uncertain Significance

Met criteria codes 2
PM3_Supporting PM2_Supporting
Not Met criteria codes 2
PP4 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The NM_000419.5(ITGA2B):c.2489T>G (p.Leu830Arg) missense variant has been reported in at least one homozygous patient (UPN 9 in PMID: 16879215; PM3_supporting). The highest population minor allele frequency in gnomAD v4.1 is 0.00001098 (1/91048 alleles) in the South Asian genetic ancestry group, which is lower than the ClinGen PD VCEP threshold (<0.0001; PM2_Supporting). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PM2_supporting, PM3_supporting.
Met criteria codes
PM3_Supporting
UPN 9 is homozygous for this variant (PM3_supporting; PMID: 16879215).
PM2_Supporting
The highest population minor allele frequency in gnomAD v4.1 is 0.00001098 (1/91048 alleles) in the South Asian genetic ancestry group, which is lower than the ClinGen PD VCEP threshold (<0.0001; PM2_Supporting).
Not Met criteria codes
PP4
UPN 9 (PMID: 16879215) has a history of mucocutaneous bleeding as well as absent platelet aggregation in response to ADP, epinephrine, and collagen but also has a poor ristocetin response. Additionally, αIIbβ3 surface expression was reduced to 10%, as measured by flow cytometry.
PP3
The computational predictor REVEL gives a score of 0.568, which is below the ClinGen PD VCEP PP3 threshold of >0.7 and does not predict a damaging effect on ITGA2B function. And the computational splicing predictor SpliceAI indicated that the variant is not likely to have an impact on splicing (though a possible acceptor site gain is reported with a score of 0.23).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.